Insider Trading July 8, 2026 06:46 PM

Jewett-Cameron Trading Company Insider Activity Analysis

Fund and Affiliates Increase Holdings Amid Financial Headwinds

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
JCTC

AJB Investment Fund II, LP, along with affiliated entities and individuals Adam J. Bradley and Melinda Bradley, have increased their stake in Jewett-Cameron Trading Co Ltd (NASDAQ:JCTC) through recent open market purchases. The transactions, totaling $86,410, occurred on July 7 and July 8, 2026, with share prices ranging from $2.485 to $2.5199. This insider buying activity comes as the stock trades at $2.48, reflecting a 33% decline over the past year but showing recent momentum. According to InvestingPro analysis, JCTC appears undervalued at current levels, placing it among stocks on the platform's Most Undervalued list. The aggregate beneficial ownership of the reporting persons now stands at 416,404 shares, with Adam J. Bradley deemed to beneficially own all shares due to his direct ownership and control of AJB Capital, LLC. Melinda Bradley is deemed to beneficially own 372,010 shares. These purchases occur amid challenging fundamentals for the $8.73 million market cap company, which reported a 11% revenue increase in the second quarter of fiscal year 2026 but faced a net loss of $0.6 million. No changes in stock price were noted following the announcement, and there were no updates regarding mergers or acquisitions. Additionally, no analyst upgrades or downgrades were reported for Jewett-Cameron Trading Company.

Jewett-Cameron Trading Company Insider Activity Analysis
JCTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • AJB Investment Fund II, LP, and affiliated individuals Adam J. Bradley and Melinda Bradley purchased $86,410 worth of Jewett-Cameron Trading Co Ltd (NASDAQ:JCTC) stock on July 7 and July 8, 2026.
  • The aggregate beneficial ownership of the reporting persons now stands at 416,404 shares, with Adam J. Bradley deemed to beneficially own all shares due to his direct ownership and control of AJB Capital, LLC.
  • JCTC reported an 11% revenue increase in the second quarter of fiscal year 2026, reaching $9.1 million, but faced a net loss of $0.6 million, highlighting ongoing financial challenges.

AJB Investment Fund II, LP, along with affiliated entities and individuals Adam J. Bradley and Melinda Bradley, have executed open market purchases of Jewett-Cameron Trading Co Ltd (NASDAQ:JCTC) stock. The collective acquisition totaled $86,410, with transactions taking place on July 7 and July 8, 2026. Share prices during these purchases ranged from $2.485 to $2.5199. All reporting persons are classified as 10% owners of the company. The insider buying activity emerges as the stock trades at $2.48, marking a 33% decline over the past year but showing momentum with strong returns over recent months. According to InvestingPro analysis, JCTC appears undervalued at current levels, placing it among stocks on the platform's Most Undervalued list.

According to a recent SEC Form 4 filing, the reporting persons collectively purchased 34,388 shares of JCTC common stock through open market transactions. On July 7, 2026, the reporting entities and individuals indirectly acquired 5,000 shares at $2.51 per share. Further acquisitions on the same day included 5,000 shares at a weighted average price of $2.5107, with prices ranging from $2.5100 to $2.5150. Another 5,000 shares were purchased at a weighted average of $2.5114, within a price range of $2.5100 to $2.5150. Additional transactions on July 7 involved 5,000 shares at a weighted average of $2.5175 (range $2.5070-$2.5250) and 5,000 shares at a weighted average of $2.5179 (range $2.5050-$2.5250). The day's purchases also included 5,100 shares at a weighted average of $2.5061 (range $2.5050-$2.5600) and 3,900 shares at a weighted average of $2.5199 (range $2.5050-$2.5300).

On July 8, 2026, an additional 388 shares were acquired at $2.485 per share. Following these transactions, the aggregate beneficial ownership of the reporting persons stands at 416,404 shares. This total includes 325,574 shares held by AJB Investment Fund II, LP; 31,809 shares in an individual retirement account for Adam J. Bradley; 46,436 shares in an individual retirement account for Melinda Bradley; and 12,585 shares held in accounts owned by their adult children, over which Adam J. Bradley exercises investment discretion. Adam J. Bradley is deemed to beneficially own all 416,404 shares due to his direct ownership, his control of AJB Capital, LLC, and his investment discretion over certain accounts. Melinda Bradley is deemed to beneficially own 372,010 shares, comprising shares held by AJB Investment Fund II, LP (over which she shares voting and dispositive power as a managing member of AJB Capital) and shares in her individual retirement account. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest.

The insider purchases come amid challenging fundamentals for the $8.73 million market cap company. JCTC posted revenue of $42.17 million in the last twelve months as of Q2 2026, down 11% year-over-year, with a weak gross profit margin of just 7.86%. InvestingPro assigns the company a "WEAK" financial health score and highlights concerns including cash burn and profitability challenges. For investors seeking deeper analysis, InvestingPro offers 6 additional exclusive tips for JCTC, plus comprehensive Pro Research Reports covering this and 1,400+ other US equities with actionable intelligence.

In other recent news, Jewett-Cameron Trading Company reported an 11% increase in revenue for the second quarter of fiscal year 2026, reaching $9.1 million, compared to $8.2 million in the same period last year. Despite the revenue growth, the company faced a net loss of $0.6 million, or $0.16 per share, contrasting with a net income of $0.5 million, or $0.15 per share, in the second quarter of fiscal year 2025. These developments highlight the financial challenges the company is currently navigating. No changes in stock price were noted following this announcement. There were no updates regarding mergers or acquisitions in this period. Additionally, no analyst upgrades or downgrades were reported for Jewett-Cameron Trading Company. Investors continue to monitor the company's performance closely amid these recent developments.

Risks

  • JCTC posted revenue of $42.17 million in the last twelve months as of Q2 2026, down 11% year-over-year, with a weak gross profit margin of just 7.86%.
  • InvestingPro assigns the company a "WEAK" financial health score and highlights concerns including cash burn and profitability challenges.
  • The company faced a net loss of $0.6 million, or $0.16 per share, contrasting with a net income of $0.5 million, or $0.15 per share, in the second quarter of fiscal year 2025.

More from Insider Trading

Puma Biotechnology CEO Alan Auerbach Executes $364K Stock Sale Under Pre-Arranged Plan Jul 8, 2026 Puma Biotechnology Executive Sells Shares Under Pre-Arranged Plan Amid Stock Rally Jul 8, 2026 Omada Health CFO Craig Gracey Executes $85K Sale Under Pre-Arranged Plan Jul 8, 2026 Omada Health Executive Craig Gracey Divests Stock Under Pre-Arranged Trading Plan Jul 8, 2026 Omada Health CFO Steven Cook Executes $1.03M Stock Sale Under Pre-Arranged Plan Jul 8, 2026